Today's Medical Developments, Pam Streed
In the already fiercely competitive medical device industry, manufacturers seek the advantage of being the first to incorporate new technology, such as wireless connectivity, into their latest devices. However, manufacturers are also well aware of the delicate balance between ensuring their products represent the quality they promise and staying ahead of the competition.
Creating a high quality product that will meet the medical community’s expectations begins during the product design and development process. Third-party testing partners can be a tremendous resource to manufacturers during these early stages of product design, bringing an external perspective on industry standards that can shed light on opportunities to improve product attributes.
Accepted standards exist to ensure the safe and reliable performance of medical devices. As new technologies emerge, standards will evolve to incorporate these new technologies. There are also numerous areas of crossover among standards; for instance, a medical device that has a light may need to be tested against lighting and medical device standards, whereas a medical device that incorporates wireless technology will have to meet Federal Communications Commission (FCC) requirements in addition to the safety requirements for medical devices. . .View Full Article
Notable Quotes
"I think GALE has a good shot on its phase 3 NeuVax trial." (5/23/13) Galena Biopharma Inc. - The Life Sciences Report Interview with Echo He More >
"BTI's Transcend platform is a huge financial incentive to the owner of the therapy because it could greatly extend the drug's exclusivity." (5/16/13) biOasis Technologies Inc. - The Life Sciences Report Interview with William Gregozeski More >
"ATHX is a neat little company that has a great management team and deep science bench." (5/10/13) Athersys Inc. - The Life Sciences Report Interview with Jason Kolbert More >
"MSLP was growing very fast, and it had significant events that made it possible for us to raise $12M for it." (4/25/13) MusclePharm Corp. - The Life Sciences Report Interview with Richard Huebner More >
"What's particularly exciting about VNRX is that it believes its technology is able to identify targeted cancers in stage 1 and stage 2." (4/25/13) VolitionRx Ltd. - The Life Sciences Report Interview with Dick Huebner More >
Early Third-Party Testing Benefits Medical Devices Producers
Source: Today's Medical Developments, Pam Streed (4/2/12)
"Early engagement of third-party testing partner yields significant benefits to medical device manufacturers."
More Experts
"NEO is a small but focused diagnostic company with numerous competitive advantages." (4/4/13) NeoGenomics Laboratories - The Life Sciences Report Interview with Grant Zeng More >
"The Abstral acquisition has transformed GALE from a development biotech company into a commercial organization." (4/4/13) Galena Biopharma Inc. - The Life Sciences Report Interview with Grant Zeng More >
"I believe the monoclonal antibody technology that SYN is working on for pertussis is especially interesting." (3/28/13) Synthetic Biologics Inc. - The Life Sciences Report Interview with Keith Markey More >
"ATHX has one of the best manufacturing processes in allogeneic cell therapy I've ever seen." (3/14/13) Athersys Inc. - The Life Sciences Report Interview with Jason Kolbert More >
"If phase 2b ASSURE trial results show a significant decrease in atherosclerotic plaque volume, it will be a huge win for RVX." (3/7/13) Resverlogix Corp. - The Life Sciences Report Interview with George Zavoico More >
The Life Sciences Report